Search results
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via Yahoo News· 2 days agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...
Experts develop way to harness CRISPR technology to deal with antimicrobial resistance
Phys.org· 1 hour agoCRISPR-Cas gene-editing technology is a groundbreaking method in molecular biology that allows for...
Mammoth Biosciences to Receive $100M Upfront in Therapeutic CRISPR Gene Editing Deal With Regeneron
GenomeWeb News· 1 day agoAs part of the deal, Mammoth will receive a $95 million equity investment and a $5 million upfront payment from Regeneron at signing. Mammoth, cofounded by Jennifer
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Seeking Alpha· 1 day agoRegeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editing...
Regeneron and Mammoth Biosciences team up on gene editing By Investing.com
Investing.com· 1 day agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) and Mammoth Biosciences have announced a...
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive via Yahoo Finance· 2 days agoThe Brisbane, California-based company began testing CRISPR technology for COVID-19 diagnostic tests. In 2023, it switched gears to develop...
Weekly AI Recap: Meta shares suffer, even as the company continues to ship new AI features
The Drum· 7 hours agoInvestors got spooked, however, by Meta’s plans to push more money into AI R&D – an area which Meta has been expanding into rapidly but which is not yet profitable for the company. Meta chief ...
Roxane Cohen Silver elected to the American Academy of Arts & Sciences
Newswise· 3 days agoAcclaimed psychologist Roxane Cohen Silver of the University of California, Irvine – whose groundbreaking studies on stress and coping have advanced understanding of how traumatic incidents ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoOral presentation to discuss CRISPR-associated gene editing inactivating herpes virusTwo poster presentations highlight the potential of EBT-104 for the treatment of HSV-1 Keratitis, demonstrating near-complete virus elimination in vitro and a
Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV...
Morningstar· 4 days agoSAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious latent viral infectious diseases, today announced
